Literature DB >> 71525

Polymorphic hydroxylation of debrisoquine.

G T Tucker, J H Silas, A O Iyun, M S Lennard, A J Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 71525     DOI： 10.1016/s0140-6736(77)90527-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  29 in total

Review 1.  Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors:  Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

2.  Research priorities in pharmacokinetics.

Authors:  Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

3.  Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Authors:  I Johansson; Q Y Yue; M L Dahl; M Heim; J Säwe; L Bertilsson; U A Meyer; F Sjöqvist; M Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

5.  Prevalence of debrisoquine oxidation phenotypes in glaucoma patients.

Authors:  L Salminen; R Lindberg; H R Toivari; R Huupponen; T Kaila; E Iisalo
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

6.  Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.

Authors:  J C McGourty; J H Silas; M S Lennard; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

7.  Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.

Authors:  J Kallio; R Lindberg; R Huupponen; E Iisalo
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

8.  The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.

Authors:  J C Bloomer; F R Woods; R E Haddock; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

9.  Debrisoquine oxidation polymorphism in a Tasmanian population.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.